Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 24, 2007
Results reaffirm strength of Boston Scientific's dual drug-eluting stent program
-
Mar 23, 2007
Compliance program is the first of its kind in the medical device industry; is expected to launch in the United States later this year
-
Mar 22, 2007
Smallest Dual Chamber System offered in Japan provides enhanced therapies to patients at risk of sudden cardiac death
-
Mar 20, 2007Company to host analyst meeting and symposium on drug-eluting stents
Company to host analyst meeting and symposium on drug-eluting stents
-
Mar 13, 2007
A live webcast and replay of the March 19 conference session will be available
-
Mar 12, 2007
IPO would involve Boston Scientific selling approximately 20 percent of the Endosurgery group and establishing a separately traded public company
-
Mar 8, 2007
Boston Scientific Corporation (NYSE: BSX) today announced several enhancements related to the governance of the company. "Boston Scientific is...
-
Mar 6, 2007
A live webcast and replay of the March 13 conference session will be available
-
Mar 5, 2007
Company looks forward to providing the Committee the information it has requested relating to TAXUS® paclitaxel-eluting coronary stents
-
Feb 28, 2007
Campaign spokesperson - a Formula race car driver, amputee, and chronic pain patient - to promote public awareness